F23-9340393-6/30002/2

GlaxoSmithKline Manufacturing S.p.A. — FEI 3002807114

Refusal Details

Date
September 3, 2025
Country
Italy
Product Category
Drugs and Biologics
Product Code
58MCY20 BELIMUMAB
Charges
75